Revascularization for Heart Failure: Can We Do Better?

Affiliations

¹ Program for Advanced Coronary Disease, Division of Cardiology, Duke University, Durham, North Carolina; Duke University and Duke Clinical Research Institute, Durham, North Carolina. Electronic address: ohman001@mc.duke.edu.
² Duke University and Duke Clinical Research Institute, Durham, North Carolina.

Free article

Editorial

E Magnus Ohman et al. JACC Heart Fail. 2018 Jun.

Free article

. 2018 Jun;6(6):527-529.

doi: 10.1016/j.jchf.2018.05.002.

¹ Program for Advanced Coronary Disease, Division of Cardiology, Duke University, Durham, North Carolina; Duke University and Duke Clinical Research Institute, Durham, North Carolina. Electronic address: ohman001@mc.duke.edu.
² Duke University and Duke Clinical Research Institute, Durham, North Carolina.

No abstract available

Keywords: heart failure; ischemic cardiomyopathy; left ventricular dysfunction; myocardial viability; percutaneous coronary intervention.

Comment on

Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.
Perera D, Clayton T, Petrie MC, Greenwood JP, O'Kane PD, Evans R, Sculpher M, Mcdonagh T, Gershlick A, de Belder M, Redwood S, Carr-White G, Marber M; REVIVED investigators. Perera D, et al. JACC Heart Fail. 2018 Jun;6(6):517-526. doi: 10.1016/j.jchf.2018.01.024. JACC Heart Fail. 2018. PMID: 29852933